Sebastian Ulrike Franz-Rudolf Anselm Norbert Tilman Jens And Noé Spengler Fendler Bäumer Schön Unger

Novel Insights into the Management of Patients with Very High Cardiovascular Risk Eligible for PCSK9 Inhibitor Treatment: Baseline Findings from the PERI-DYS Study

U. Laufs, E. Steinhagen-Thiessen, J. Klotsche, 2022, Cardiovascular drugs and therapy.